1. Home
  2. RLAY vs DFIN Comparison

RLAY vs DFIN Comparison

Compare RLAY & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.69

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$45.97

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
DFIN
Founded
2015
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RLAY
DFIN
Price
$7.69
$45.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
2
Target Price
$16.00
$63.50
AVG Volume (30 Days)
2.1M
231.5K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.12
Revenue
$8,355,000.00
$750,800,000.00
Revenue This Year
$20.47
N/A
Revenue Next Year
N/A
$4.20
P/E Ratio
N/A
$40.82
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$37.80
52 Week High
$8.36
$69.93

Technical Indicators

Market Signals
Indicator
RLAY
DFIN
Relative Strength Index (RSI) 58.73 42.22
Support Level $7.23 $47.58
Resistance Level $8.36 $49.55
Average True Range (ATR) 0.51 1.36
MACD 0.05 0.26
Stochastic Oscillator 69.18 30.59

Price Performance

Historical Comparison
RLAY
DFIN

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

Share on Social Networks: